Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Nov-16 5:26 PM View:  | Frazier Healthcare V, Lp 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 2,668,570 | $28.35 | $75,654,000.00 | (100%) 2.67M to 0 | |
| 03-Nov-16 2:32 PM View: | Weber Eckard Director | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 243,726 | -- | -- | (100%) 243.73K to 0 | |
| 04-Nov-16 8:30 AM View: | Domain Associates 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 38,094 | $28.35 | $1,079,960.00 | (100%) 38.09K to 0 | |
| 03-Nov-16 2:28 PM View: | Fromkin Drew J Director | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 11 | -- | -- | (69%) 16 to 5 | |
| 03-Nov-16 9:42 PM View: | Domain Partners Vi, L.P. 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 285,679 | $28.35 | $8,099,000.00 | (100%) 285.68K to 0 | |
| 03-Nov-16 9:47 PM View: | Domain Parters Vii L P 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 3,553,320 | $28.35 | $100,737,000.00 | (100%) 3.55M to 0 | |
| 03-Nov-16 9:54 PM View: | Dp Vi Associates, L.P. 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 1,657 | $28.35 | $46,975.90 | (100%) 1.66K to 0 | |
| 03-Nov-16 2:28 PM View: | Fromkin Drew J Director | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 5 | -- | -- | (100%) 5 to 0 | |
| 03-Nov-16 9:45 PM View: | Dp Vii Associates Lp 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 01-Nov-16 | Disposition (change in control) | 47,613 | $28.35 | $1,349,830.00 | (100%) 47.61K to 0 | |
| 02-Nov-16 5:00 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 31-Oct-16 | Market Purchase | 15,000 | $41.84 | $627,600.00 | < 1% 3.74M to 3.76M | |
| 19-Oct-16 5:00 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 18-Oct-16 | Market Purchase | 8,300 | $40.04 | $332,332.00 | < 1% 3.73M to 3.74M | 4% |
| 19-Oct-16 5:00 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 17-Oct-16 | Market Purchase | 31,700 | $40.07 | $1,270,270.00 | < 1% 3.7M to 3.73M | 4% |
| 06-Oct-16 5:00 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 04-Oct-16 | Market Purchase | 4,481 | $39.83 | $178,478.00 | < 1% 3.7M to 3.7M | 5% |
| 30-Sep-16 5:41 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 29-Sep-16 | Market Purchase | 15,519 | $39.49 | $612,845.00 | < 1% 3.68M to 3.7M | 6% |
| 28-Sep-16 6:00 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 26-Sep-16 | Market Purchase | 50,000 | $39.00 | $1,950,010.00 | 1% 3.63M to 3.68M | 7% |
| 23-Sep-16 5:00 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 23-Sep-16 | Market Purchase | 100,000 | $39.19 | $3,918,500.00 | 3% 3.53M to 3.63M | 7% |
| 22-Sep-16 4:45 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 22-Sep-16 | Market Purchase | 99,000 | $39.36 | $3,896,430.00 | < 1% 10.08M to 10.18M | 6% |
| 22-Sep-16 4:45 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 21-Sep-16 | Market Purchase | 229,200 | $39.12 | $8,965,550.00 | 2% 9.65M to 9.88M | 7% |
| 22-Sep-16 4:45 PM View: | Pentwater Capital Managemen... 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 20-Sep-16 | Market Purchase | 1,296,000 | $39.00 | $50,548,100.00 | 16% 8.31M to 9.61M | 7% |
| 13-Jul-16 6:26 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 13-Jul-16 | Market Sale | 29,884 | $11.88 | $354,944.00 | (2%) 1.91M to 1.88M | (252%) |
| 13-Jul-16 6:26 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 12-Jul-16 | Market Sale | 8,752 | $12.12 | $106,072.00 | (< 1%) 1.91M to 1.91M | (245%) |
| 13-Jul-16 6:26 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 11-Jul-16 | Market Sale | 20,431 | $12.19 | $249,101.00 | (1%) 1.93M to 1.91M | (243%) |
| 07-Jul-16 6:46 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 07-Jul-16 | Market Sale | 21,869 | $12.03 | $263,150.00 | (1%) 1.96M to 1.93M | (248%) |
| 07-Jul-16 6:46 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 06-Jul-16 | Market Sale | 59,850 | $12.20 | $730,272.00 | (3%) 2.02M to 1.96M | (243%) |
| 07-Jul-16 6:46 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 05-Jul-16 | Market Sale | 10,400 | $12.57 | $130,709.00 | (< 1%) 2.03M to 2.02M | (233%) |
| 30-Jun-16 6:01 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 30-Jun-16 | Market Sale | 27,133 | $12.58 | $341,368.00 | (1%) 2.05M to 2.03M | (232%) |
| 30-Jun-16 6:01 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 29-Jun-16 | Market Sale | 16,068 | $12.63 | $202,947.00 | (< 1%) 2.07M to 2.05M | (231%) |
| 30-Jun-16 6:01 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 28-Jun-16 | Market Sale | 23,613 | $13.83 | $326,626.00 | (1%) 2.09M to 2.07M | (202%) |
| 07-Jun-16 5:08 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 06-Jun-16 | Market Sale | 187,500 | $10.37 | $1,943,910.00 | (8%) 2.28M to 2.09M | (303%) |
| 04-Mar-16 6:34 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 04-Mar-16 | Market Sale | 55,000 | $6.54 | $359,667.00 | (2%) 2.34M to 2.28M | (540%) |
| 04-Mar-16 6:34 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 03-Mar-16 | Market Sale | 25,000 | $6.86 | $171,395.00 | (1%) 2.36M to 2.34M | (510%) |
| 04-Mar-16 6:34 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 02-Mar-16 | Market Sale | 110,000 | $6.92 | $761,024.00 | (4%) 2.47M to 2.36M | (504%) |
| 19-Nov-15 5:55 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 18-Nov-15 | Market Sale | 153,601 | $9.76 | $1,498,680.00 | (6%) 2.63M to 2.47M | (329%) |
| 19-Nov-15 5:55 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 17-Nov-15 | Market Sale | 71,399 | $9.87 | $704,394.00 | (3%) 2.7M to 2.63M | (324%) |
| 06-May-15 5:35 PM View: | Domain Associates 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 04-May-15 | Acquisition (other) | 36,187 | -- | -- | 1898% 1.91K to 38.09K | |
| 06-May-15 5:26 PM View: | Domain Parters Vii L P 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 04-May-15 | Purchase | 277,777 | $10.62 | $2,949,990.00 | 8% 3.28M to 3.55M | |
| 06-May-15 6:32 PM View: | Novo A/s 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 04-May-15 | Purchase | 838,041 | $10.62 | $8,900,000.00 | 45% 1.86M to 2.7M | |
| 06-May-15 9:09 PM View: | Heron Patrick J Director | Tobira Therapeutics, Inc. (TBRA) | 04-May-15 | Grant Duplicate | 2,668,570 | -- | -- | 100% 0 to 2.67M | |
| 06-May-15 9:12 PM View: | Frazier Healthcare V, Lp 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 04-May-15 | Grant | 2,668,570 | -- | -- | 100% 0 to 2.67M | |
| 07-May-15 9:31 AM View: | Weber Eckard Director | Tobira Therapeutics, Inc. (TBRA) | 04-May-15 | Grant | 3,880,850 | -- | -- | 100% 0 to 3.88M | |
| 24-Dec-14 9:03 AM View: | Kierlin Robert A 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 28-Oct-14 | Market Sale | 941,252 | $1.10 | $1,035,380.00 | (23%) 4.16M to 3.21M | (335%) |
| 24-Dec-14 9:03 AM View: | Kierlin Robert A 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 27-Oct-14 | Market Sale | 18,748 | $1.08 | $20,247.80 | (< 1%) 4.17M to 4.16M | (343%) |
| 24-Dec-14 9:03 AM View: | Kierlin Robert A 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 24-Oct-14 | Market Sale | 110,000 | $1.10 | $120,600.00 | (3%) 4.28M to 4.17M | (336%) |
| 17-Apr-14 5:33 PM View: | Kierlin Robert A 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 16-Apr-14 | Market Purchase | 575,000 | $6.00 | $3,450,000.00 | 15% 3.71M to 4.28M | (20%) |
| 25-Mar-14 5:28 PM View: | Bvf Partners L P/il | Tobira Therapeutics, Inc. (TBRA) | 21-Mar-14 | Disposition (other) | 1,441,780 | -- | -- | (32%) 4.54M to 3.1M | |
| 03-Mar-14 6:22 PM View: | Clark B. Jefferson Director | Tobira Therapeutics, Inc. (TBRA) | 20-Feb-14 | Exercise (in-the money or at-the-money) | 15,374 | $3.08 | $47,394.60 | < 1% 2.24M to 2.26M | |
| 06-Feb-14 4:18 PM View: | Kierlin Robert A 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 05-Feb-14 | Private Purchase | 400,000 | $5.00 | $2,000,000.00 | 12% 3.3M to 3.7M | |
| 28-Aug-13 12:15 PM View: | Treu Jesse I Director 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 27-Aug-13 | Purchase Duplicate | 750,000 | $4.00 | $3,000,000.00 | 40% 1.85M to 2.6M | |
| 29-Aug-13 4:34 PM View: | Clark B. Jefferson Director | Tobira Therapeutics, Inc. (TBRA) | 27-Aug-13 | Conversion | 736,138 | -- | -- | 95% 774.76K to 1.51M | |
| 29-Aug-13 4:26 PM View: | Biodiscovery 3, Fcpr 10% Owner | Tobira Therapeutics, Inc. (TBRA) | 27-Aug-13 | Conversion | 1,191,560 | -- | -- | 100% 0 to 1.19M |
